Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00481832
What this trial is testing

Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Stanford University 50
Early research (Phase 1)Study completedNCT00697684
What this trial is testing

Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphocytic Leukemia+4 more
Beth Israel Deaconess Medical Center 29
Early research (Phase 1)Study completedNCT01290549
What this trial is testing

Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma

Who this might be right for
Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Genentech, Inc. 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT05951049
What this trial is testing

AT-02 in Subjects With Systemic Amyloidosis.

Who this might be right for
Amyloidosis; Systemic
Attralus, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT01733238
What this trial is testing

Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin's
Sierra Oncology LLC - a GSK company 13
Testing effectiveness (Phase 2)Ended earlyNCT00567229
What this trial is testing

Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT06758037
What this trial is testing

Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy

Who this might be right for
DLBCLDiffuse Large B-Cell Lymphoma
First Affiliated Hospital of Ningbo University 50
Early research (Phase 1)Study completedNCT00355472
What this trial is testing

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

Who this might be right for
Adult T-Cell Leukemia and Lymphoma (ATL)Adult Peripheral T-Cell Lymphoma (PTCL)
Kyowa Kirin Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT00255801
What this trial is testing

Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 37
Early research (Phase 1)Ended earlyNCT00127101
What this trial is testing

An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 23
Large-scale testing (Phase 3)Study completedNCT02203812
What this trial is testing

Effect of Probiotic Lozenge on Gingivitis and Periodontitis

Who this might be right for
Mild and Moderate Chronic Periodontitis
CD Pharma India Pvt. Ltd. 32
Testing effectiveness (Phase 2)WithdrawnNCT03191981
What this trial is testing

Pembrolizumab Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma

Who this might be right for
Myeloma Multiple
University of Leeds
Large-scale testing (Phase 3)Active Not RecruitingNCT03319667
What this trial is testing

Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Who this might be right for
Plasma Cell Myeloma
Sanofi 475
Early research (Phase 1)Study completedNCT04970992
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma

Who this might be right for
Solid TumorLymphoma
Da Zen Theranostics Inc 14
Not applicableWithdrawnNCT04311866
What this trial is testing

Femoral Pediatric Fractures. Walking Spica Cast vs Synthetic Pants

Who this might be right for
Femoral Shaft FracturePediatric ALL
Universidad Autonoma de Nuevo Leon
Early research (Phase 1)Study completedNCT00761722
What this trial is testing

Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesLymphoma+2 more
Celgene 31
Testing effectiveness (Phase 2)Study completedNCT03740529
What this trial is testing

Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

Who this might be right for
Chronic Lymphocytic LeukemiaWaldenstrom MacroglobulinemiaMantle Cell Lymphoma+3 more
Loxo Oncology, Inc. 803
Early research (Phase 1)Study completedNCT03212937
What this trial is testing

Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
National Cancer Centre, Singapore 11
Testing effectiveness (Phase 2)Ended earlyNCT00523939
What this trial is testing

DepoCyt for Active Lymphomatous or Leukemic Meningitis

Who this might be right for
Neoplastic MeningitisLymphoma, B Cell
Duke University 4
Early research (Phase 1)Study completedNCT04655677
What this trial is testing

C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
Peking Union Medical College Hospital 10
Next Page